A new study has established a strong link between prostatitis, or the inflammation of the prostate gland, and prostate cancer, Renal & Urology News reported on June 29.
The research, which involved 1,184 patients with prostate cancer and 1,965 controls, found that men with a history of prostatitis are 83% more likely to suffer from prostate cancer. The study also found that patients with prostatitis who were not been diagnosed with benign prostatic hyperplasia (enlarged prostate) were almost three times more likely to suffer from prostate cancer. On the other hand, prostatitis patients who have had an enlarged prostate before were 30% less likely to develop cancer.
Apart from prostatitis, prostate cancer has also been associated with low-t supplements. If you think a diagnosis of prostate cancer has been a result of using low-t supplements, you might be qualified to file a claim against the drug manufacturer involved. Consult with our team at the National Injury Law Center by calling (888) 273-6041 today.